| QED | Quantitative estimate of drug-likeness |
| PPI | Protein-protein interaction |
| QEPPI | Quantitative estimate index for compounds targeting protein-protein interactions |
| RO4 | Rule of four |
| RO5 | Rule of five |
| PPI | Protein-protein interaction |
| FDA | The U.S. Food and Drug Administrations |
| MW | Molecular weight |
| ALogP | LogP value estimated by the Wildman-Crippen method |
| HBD | The number of hydrogen bond donors |
| HBA | The number of hydrogen bond acceptors |
| TPSA | Topological molecular polar surface area |
| ROBT | The number of rotatable bonds |
| AROM | The number of aromatic rings |
| RING | The number of ring structures |
| ALERTS | The number of structural alerts |
| ROC | Receiver operating characteristic |
| AUC | Area under the curve |
| WGAN | Wasserstein generative adversarial network |
| VAE | Variational Autoencoder |
| TTR | Transthyretin |
| PAINS | Pan assay interfering compounds |